← Back to Search

Nutritional Ketosis

Virtual Lifestyle Intervention for Type 2 Diabetes (VICTOR Trial)

N/A
Waitlist Available
Led By Cecilia Low Wang, MD
Research Sponsored by Colorado Prevention Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up group 1: baseline, 3.5 months and 7 months / group 2: 3.5 months and 7 months
Awards & highlights

VICTOR Trial Summary

This trialwill evaluate whether individuals in rural communities accept a virtual lifestyle intervention to improve glucose control in those with type 2 diabetes.

Who is the study for?
The VICTOR-Pilot study is for adults aged 18-79 with type 2 diabetes who are overweight, have an HbA1c level over 7.5%, and take medication for diabetes. Participants should be able to engage in virtual care and give electronic consent. Those with severe health conditions, recent serious diabetic complications, or women who are pregnant/planning pregnancy within nine months cannot join.Check my eligibility
What is being tested?
This trial tests the Virta Health program's acceptability and effectiveness in rural Colorado communities. The program uses a virtual lifestyle intervention that induces nutritional ketosis to control blood sugar levels in people with type 2 diabetes.See study design
What are the potential side effects?
While specific side effects aren't listed here, interventions like Virta Health that induce nutritional ketosis may cause symptoms such as fatigue, headache, dizziness or digestive issues during the initial adjustment period.

VICTOR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~group 1: baseline, 3.5 months and 7 months / group 2: 3.5 months and 7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and group 1: baseline, 3.5 months and 7 months / group 2: 3.5 months and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in hemoglobin A1c (Percent)
Secondary outcome measures
Change in BMI
Change in hemoglobin A1c
Change in number and/or doses of anti-hyperglycemic medications • doses of anti-hyperglycemic medications
Other outcome measures
Acceptability of referral
Acceptability of referral over time
Acceptance of referral to continuous remote care
+8 more

VICTOR Trial Design

2Treatment groups
Active Control
Group I: CHHS Standard Care - Delayed Referral to Nutritional Ketosis InterventionActive Control1 Intervention
All subjects will be enrolled in Colorado Heart Healthy Solutions (CHHS), which consists of community health worker (CHW) contact and sessions on: 1) cardiovascular disease knowledge; 2) Health behavior change through skill building to improve diet (e.g., portion sizes, increasing fruit/vegetable intake, reducing intake of sugar sweetened beverages, decreasing fast food meals, etc.), increase physical activity, and improve well-being, tailored to individual subjects' risk profile and self-identified goals; and 3) Connection to services including primary care, mental health services if needed, and relevant community programs to address barriers (e.g. food insecurity, need for legal help) or to promote behavior change (e.g. free/low cost exercise programs).
Group II: Nutritional Ketosis Intervention ReferralActive Control1 Intervention
The comprehensive remotely-delivered continuous remote care to induce nutritional ketosis combined with remote medication management is the Virta treatment, and while on this treatment, subjects will have access to Virta health coaches and licensed medical providers who will perform medical therapy management, health coaching, nutrition and behavior change education, biometric feedback, and the option to participate in a community for peer support.

Find a Location

Who is running the clinical trial?

Colorado Prevention CenterLead Sponsor
12 Previous Clinical Trials
22,574 Total Patients Enrolled
Virta HealthIndustry Sponsor
4 Previous Clinical Trials
50,945 Total Patients Enrolled
Cecilia Low Wang, MDPrincipal InvestigatorCPC Clinical Research
1 Previous Clinical Trials
16 Total Patients Enrolled
~14 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top